Related Experiment Video

Updated: Oct 9, 2026

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
08:45

Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors

Published on: July 17, 2020

Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor

M M Georgescu1, K H Kirsch, P Kaloudis

  • 1Laboratory of Molecular Oncology, The Rockefeller University, New York, New York 10021, USA. georgem@rockvax.rockefeller.edu

Cancer Research
|January 13, 2001
PubMed

Insights

The PTEN C2 domain is crucial for tumor suppression. It stabilizes the protein and correctly positions the active site for lipid binding, impacting cancer growth.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • PTEN (Phosphatase and tensin homolog) is a critical tumor suppressor gene frequently inactivated in various cancers, including brain, prostate, and uterine malignancies.
  • PTEN functions as a phosphoinositide phosphatase, with its activity dependent on both the N-terminal phosphatase domain and the C-terminal C2 domain, which mediates lipid membrane binding.

Purpose of the Study:

  • To elucidate the specific functions of the PTEN C2 domain in relation to tumor growth.
  • To differentiate between the C2 domain's roles in recruiting the enzyme to the membrane versus positioning its active site for substrate interaction.

Main Methods:

  • Artificial membrane targeting of PTEN using a myristoylation signal to investigate C2 domain function.
  • Analysis of tumor-derived mutations within the C2 domain's beta-strand connecting loops to assess their impact on protein stability and enzymatic activity.

Main Results:

  • Artificial membrane targeting enhanced wild-type PTEN's growth inhibitory effects but did not rescue a C2 mutant deficient in lipid binding.
  • Tumor-associated mutations in C2 loops generally destabilized PTEN, with variable impacts on phosphatase activity and tumor suppression, influenced by PEST sequences and cell type.
  • One specific C2 loop mutant completely abolished PTEN's tumor suppressor function, likely by disrupting both membrane binding and protein stability.

Conclusions:

  • The PTEN C2 domain plays a dual role in maintaining protein stability and ensuring the productive orientation of the catalytic site towards membrane-bound substrates.
  • Understanding the C2 domain's functions is vital for comprehending PTEN's tumor suppressor mechanisms and developing targeted cancer therapies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...